South Korea secures 23 million additional vaccine doses from Novavax and Pfizer
South Korea has secured additional COVID-19 vaccine doses for 23 million people through agreements with Novavax and Pfizer, with deliveries expected in the second quarter of 2021.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthSouth Korea secures 23 million additional vaccine doses from Novavax and Pfizer
Sign in or subscribeBrowse free archive reportsSouth Korea has secured additional COVID-19 vaccine doses for 23 million people through agreements with Novavax and Pfizer, with deliveries expected in the second quarter of 2021.